Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
case-study
Syner-G Brings a New Radiopharmaceutical Facility Toward GMP Operational Readiness
Read More
case-study
Transforming Product & Portfolio Management Through Responsible, Human-Centric AI
Read More
infographic
Everyone Is Talking About AI. Few Are Scaling It
Read More
post
The Road to Regulatory Modernization: FDA Modernization Act 3.0, NAMs, and the Future of Nonclinical Testing
Read More
Let's move from science to success.
Let’s Talk